Try our Advanced Search for more refined results

September 07, 2017

Robert Berg v. Kite Pharma, Inc. et al

Track this case

Case Number:

2:17-cv-06583

Court:

California Central

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Michael W. Fitzgerald

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 07, 2017

    Kite Pharma Investors Balk At $11.9B Gilead Deal

    Kite Pharma Inc. didn't ask for enough money from Gilead Sciences Inc. when it agreed to be bought last month, according to a proposed class of investors who alleged in a California federal suit Thursday that the biopharmaceutical company is worth more than the pitched $12 billion.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login